Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.327 GBX | -1.70% | -7.02% | -80.22% |
22/02 | Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024 | |
21/02 | FTSE 100 takes hit ahead of FOMC minutes | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-80.22% | 13.25M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.63% | 22.18B | |
-16.67% | 21.2B | |
-8.54% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- STX Stock
- News Shield Therapeutics plc
- Shield Therapeutics' : Projected FY20 Revenue Boosted by Payment for License Agreement